Navigation Links
Children's hay fever relieved by cellulose power without adverse effects
Date:6/28/2011

A cellulose powder has been used increasingly for many years against allergic rhinitis. Still, there has been a shortage of scientific evidence for its efficacy in seasonal allergic rhinitis (hay fever), particularly in children. Now, however, scientists from the Sahlgrenska Academy and the Department of Plant and Environmental Sciences at the University of Gothenburg have proven that the cellulose powder reduces symptoms of seasonal allergic rhinitis in children, without any adverse effects.

The powder is produced from pine trees and forms a barrier on the mucous membrane when puffed into the nose. This means that allergy causing substances are filtered out.

"The cellulose powder has no adverse effects, and this fact makes it a particularly attractive treatment for children. It is used increasingly in many countries, but there is until now no scientific study proving the efficacy of the cellulose powder in children during the pollen season", is the comment from Nils berg, associate professor at the Department of Pediatrics and consultant at the Queen Silvia Children's Hospital.

Therefore, a study was carried out at the Queen Silvia Children's Hospital in Gothenburg during the birch pollen season in spring 2009. The cellulose powder was compared with a placebo (a substance without any medical effect). Fifty-three children and adolescents aged 8-18 years with allergic reaction to pollen participated in the study, lasting for 4 weeks when they puffed the powder in the nose3 times daily. Every day they also were on an antihistamine tablet (the most common treatment of hay fever). Reminders and reporting of symptom scores were performed using SMS messaging on mobile phones.

Pollen occurrence was measured every day on the roof of the hospital, and the pollen counts subsequently were analysed in relation to the symptoms reported by the children. Further data for the study came from previously unpublished statistics of pollen levels collected for 31 years at the same location in Gothenburg, from 1979 to 2009.

"We showed that the nasal symptoms of the children were significantly reduced in those who used the cellulose powder. The best effect was obtained at low to moderate concentrations of pollen, corresponding to the predominating levels in the area during the 31-year period. Furthermore, no adverse effects of the cellulose powder were seen", Nils berg remarks. He concludes:

"The complete absence of adverse effects makes this treatment admirably suited to self-care, and particularly for the treatment of children. Controlled scientific studies such as the present also provide the healthcare system a basis for testing this product as a supplement to other treatments. It is often necessary to combine different agents, at least for parts of the pollen season."

HAY FEVER

Hay fever (seasonal allergic rhinitis) is caused by pollen allergy. It is the most common allergic condition, and approximately one third of Swedish young people is afflicted. Inhalation of the allergenic substances gives rise to symptoms of running nose, itching, sneezing and nasal congestion, often with symptoms also in the eyes and airways. Antihistamine tablets are the most common treatment, but cortisone nasal spray is also often used.


'/>"/>

Contact: Nils berg
nils.aberg@vgregion.gu.se
46-706-630-567
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
2. Parents Want Electronic Access to Their Childrens Docs: Survey
3. Researchers warn of fever from the forest
4. FDA Advisers Urge Infant Doses for Kids OTC Fever Relievers
5. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
6. Fever During Pregnancy, Diabetes and Obesity May Raise Autism Risk
7. Kids Eczema, Hay Fever Linked to Allergic Asthma Later
8. Childhood eczema and hay fever leads to adult allergic asthma
9. Firstborn Kids Seem to Have More Food Allergies, Hay Fever
10. Shar-Pei Dogs Shed Light on Human Fever Syndromes
11. Kids Fevers May Not Always Need Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: